Skip to Main Content

Author Details

Stephanie Curry
Space Sciences Laboratory University of California Berkeley CA USA.
2004
128
16
PMIDPaper TitleJournal TitlePublished Year
35865912A Statistical Investigation of Factors Influencing the Magnetotail Twist at Mars.Geophys Res Lett2022
33380758Plasma Double Layers at the Boundary Between Venus and the Solar Wind.Geophys Res Lett2020
31527040Interplay of Amino Acid Residues at Positions 28 and 31 in NS5A Defines Resistance Pathways in HCV GT2.Antimicrob Agents Chemother2019
29681153Discovery of MK-6169, a Potent Pan-Genotype Hepatitis C Virus NS5A Inhibitor with Optimized Activity against Common Resistance-Associated Substitutions.J Med Chem2018
30150466In Vitro Antiviral Profile of Ruzasvir, a Potent and Pangenotype Inhibitor of Hepatitis C Virus NS5A.Antimicrob Agents Chemother2018
27808515Discovery of Ruzasvir (MK-8408): A Potent, Pan-Genotype HCV NS5A Inhibitor with Optimized Activity against Common Resistance-Associated Polymorphisms.J Med Chem2017
28228479Unraveling the structural basis of grazoprevir potency against clinically relevant substitutions in hepatitis C virus NS3/4A protease from genotype 1a.J Biol Chem2017
28416549Antiviral Activity and Resistance Analysis of NS3/4A Protease Inhibitor Grazoprevir and NS5A Inhibitor Elbasvir in Hepatitis C Virus GT4 Replicons.Antimicrob Agents Chemother2017
26926625The Combination of Grazoprevir, a Hepatitis C Virus (HCV) NS3/4A Protease Inhibitor, and Elbasvir, an HCV NS5A Inhibitor, Demonstrates a High Genetic Barrier to Resistance in HCV Genotype 1a Replicons.Antimicrob Agents Chemother2016
27792320Discovery of Chromane Containing Hepatitis C Virus (HCV) NS5A Inhibitors with Improved Potency against Resistance-Associated Variants.J Med Chem2016
27680588Structure-activity relationships of proline modifications around the tetracyclic-indole class of NS5A inhibitors.Bioorg Med Chem Lett2016
27394665Aryl or heteroaryl substituted aminal derivatives of HCV NS5A inhibitor MK-8742.Bioorg Med Chem Lett2016
27282743Discovery of potent macrocyclic HCV NS5A inhibitors.Bioorg Med Chem Lett2016
27282742Alkyl substituted aminal derivatives of HCV NS5A inhibitor MK-8742.Bioorg Med Chem Lett2016
27568086Substituted tetracyclic indole core derivatives of HCV NS5A inhibitor MK-8742.Bioorg Med Chem Lett2016
26542576MAVEN observations of the response of Mars to an interplanetary coronal mass ejection.Science2015
26303801Susceptibilities of genotype 1a, 1b, and 3 hepatitis C virus variants to the NS5A inhibitor elbasvir.Antimicrob Agents Chemother2015
26542579Early MAVEN Deep Dip campaign reveals thermosphere and ionosphere variability.Science2015
25266289Virologic resistance analysis from a phase 2 study of MK-5172 combined with pegylated interferon/ribavirin in treatment-naive patients with hepatitis C virus genotype 1 infection.Clin Infect Dis2014
25734146Clinical Implications of Detectable Baseline Hepatitis C Virus-Genotype 1 NS3/4A-Protease Variants on the Efficacy of Boceprevir Combined With Peginterferon/Ribavirin.Open Forum Infect Dis2014
23454058Antiviral activity of boceprevir monotherapy in treatment-naive subjects with chronic hepatitis C genotype 2/3.J Hepatol2013
224726925-Benzothiazole substituted pyrimidine derivatives as HCV replication (replicase) inhibitors.Bioorg Med Chem Lett2012
23036957Synthesis and SAR of geminal substitutions at the C5' carbosugar position of pyrimidine-derived HCV inhibitors.Bioorg Med Chem Lett2012
22814211Pyridofuran substituted pyrimidine derivatives as HCV replication (replicase) inhibitors.Bioorg Med Chem Lett2012
22858143Synthesis and SAR of pyridothiazole substituted pyrimidine derived HCV replication inhibitors.Bioorg Med Chem Lett2012
21797597Search for production of invisible final states in single-photon decays of Υ(1S).Phys Rev Lett2011
21866995Observation of the decay B- ⿿ D(s)((*)+) K- ⿿- ν(⿿).Phys Rev Lett2011
20366358Measurement of |V(cb)| and the form-factor slope in B --> Dl- nu(l) decays in events tagged by a fully reconstructed B meson.Phys Rev Lett2010
21231035Search for f(J)(2220) in radiative J/Ï¿ decays.Phys Rev Lett2010
20868092Measurement of D0-D0 mixing parameters using D0 â¿¿ K(S)(0)Ï¿+ Ï¿- and D0 â¿¿ K(S)(0)K+ K- decays.Phys Rev Lett2010
20867905Measurements of charged current lepton universality and |Vus| using tau lepton decays to e- ν(e) ν(Ͽ), μ- ν(μ) ν(Ͽ), Ͽ- ν(Ͽ), and K- ν(Ͽ).Phys Rev Lett2010
20867628Evidence for direct CP violation in the measurement of the Cabbibo-Kobayashi-Maskawa angle γ with B⿿ ⿿ D(*)K(*)⿿ decays.Phys Rev Lett2010
20866959Test of lepton universality in Υ(1S) decays at BABAR.Phys Rev Lett2010
20481982Search for charged lepton flavor violation in narrow upsilon decays.Phys Rev Lett2010
20366586Searches for Lepton flavor violation in the decays tau{+/-}-->e{+/-}gamma and tau{+/-}-->mu{+/-}gamma.Phys Rev Lett2010
19257181Measurement of the e;{+}e;{-}-->bb[over ] Cross Section between sqrt[s]=10.54 and 11.20 GeV.Phys Rev Lett2009
20366249Search for invisible decays of the Upsilon(1S).Phys Rev Lett2009
20366141Precise measurement of the e+e- --> pi+pi-(gamma) cross section with the initial state radiation method at BABAR.Phys Rev Lett2009
20366028Measurement of B-->K{*}(892)gamma branching fractions and CP and Isospin asymmetries.Phys Rev Lett2009
20366027Measurement of D{0}-D[-over]{0} mixing from a time-dependent amplitude analysis of D{0}-->K+pi{-}pi{0} decays.Phys Rev Lett2009
19905799Search for a low-mass higgs boson in Upsilon(3S)-->gammaA(0), A(0)-->tau(+)tau(-) at BABAR.Phys Rev Lett2009
19905689Evidence for the eta(b)(1S) meson in radiative Upsilon(2S) decay.Phys Rev Lett2009
19659341Search for second-class currents in tau;{-} --> omegapi;{-}nu_{tau}.Phys Rev Lett2009
19659196Improved limits on lepton-flavor-violating tau decays to lphi, lrho, lK, and lK.Phys Rev Lett2009
19792717Search for dimuon decays of a light scalar boson in radiative transitions Upsilon-->gammaA0.Phys Rev Lett2009
19792487Measurement of semileptonic B decays into orbitally excited charmed mesons.Phys Rev Lett2009
19747948A novel HCV NS3 protease mutation selected by combination treatment of the protease inhibitor boceprevir and NS5B polymerase inhibitors.Antiviral Res2009
19395595Identification of HCV protease inhibitor resistance mutations by selection pressure-based method.Nucleic Acids Res2009
19392508Direct CP, lepton flavor, and isospin asymmetries in the decays B-->K(*)l+l-.Phys Rev Lett2009
19392426Improved measurement of B+ --> rho+ rho0 and determination of the quark-mixing phase angle alpha.Phys Rev Lett2009
  • 1 - 50 of 128

Recommended Authors

University of California san francisco
Career Start Year 2014
Number of shared co-authors 0
Faculdade de Medicina
Career Start Year 2013
Number of shared co-authors 0
University of Regensburg
Career Start Year 2010
Number of shared co-authors 3
Kennell and Associates Inc.
Career Start Year 2010
Number of shared co-authors 3
Departement de pharmacologie et physiologie, Universite de Montreal
Career Start Year 2010
Number of shared co-authors 3
Institute of Nuclear Physics, Polish Academy of Sciences
Career Start Year 2010
Number of shared co-authors 0
University of Utah
Career Start Year 2009
Number of shared co-authors 3
Institute of High Energy Physics (IHEP), Chinese Academy of Sciences
Career Start Year 2008
Number of shared co-authors 2
Fondazione IRCCS Casa Sollievo della Sofferenza,71013
Career Start Year 2005
Number of shared co-authors 0
The Netherlands Cancer Institute
Career Start Year 2005
Number of shared co-authors 2
Nationwide Children's Hospital
Career Start Year 2003
Number of shared co-authors 13
University of California berkeley
Career Start Year 2003
Number of shared co-authors 0
Inc. 16 Dekalb Pike
Career Start Year 2002
Number of shared co-authors 0
Wellcome Sanger Institute
Career Start Year 2001
Number of shared co-authors 8
Center for Personalized Medicine, Children's Hospital Los Angeles
Career Start Year 2000
Number of shared co-authors 0
Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Career Start Year 2000
Number of shared co-authors 3
University of Texas Southwestern Medical Center
Career Start Year 1998
Number of shared co-authors 0
University of Toronto
Career Start Year 1997
Number of shared co-authors 0
Oncology R&D
Career Start Year 1997
Number of shared co-authors 0
The University of Danang-University of Science and Technology
Career Start Year 1993
Number of shared co-authors 8
The Alan Turing Institute
Career Start Year 1993
Number of shared co-authors 2
South China Agricultural University
Career Start Year 1992
Number of shared co-authors 3
University of Montreal
Career Start Year 1992
Number of shared co-authors 0
Center for Gene Regulation in Health and Disease, Cleveland State University
Career Start Year 1988
Number of shared co-authors 4
Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard
Career Start Year 1988
Number of shared co-authors 8
INFN Sezione di Bologna and University of Bologna
Career Start Year 1988
Number of shared co-authors 0
Center for Computational Biology, University of California berkeley
Career Start Year 1986
Number of shared co-authors 1
Oregon Health & Science University
Career Start Year 1985
Number of shared co-authors 0
Universite de Strasbourg, CNRS
Career Start Year 1985
Number of shared co-authors 58
Utah Center for Genetic Discovery, University of Utah
Career Start Year 1978
Number of shared co-authors 3

Collaborators

Korea University
Co-authored papers 97
Moorfields Eye Hospital
Co-authored papers 97
University of Kentucky
Co-authored papers 97
Co-authored papers 77
Co-authored papers 69
Indian Institute of Science Education and Research Pune
Co-authored papers 30
Co-authored papers 23
National Center for Biotechnology Information, National Institutes of Health
Co-authored papers 2
University of British Columbia
Co-authored papers 2
Cascade Hernia Institute
Co-authored papers 2
Co-authored papers 2
Baylor College of Medicine
Co-authored papers 2
Co-authored papers 2
Baylor College of Medicine
Co-authored papers 2
Baylor College of Medicine
Co-authored papers 2
National Center for Biotechnology Information, National Institutes of Health
Co-authored papers 2
Baylor College of Medicine
Co-authored papers 2
Lawrence Berkeley National Laboratory
Co-authored papers 2
Tianjin Institute of Environmental and Operational Medicine
Co-authored papers 2
The University of Texas MD Anderson Cancer Center
Co-authored papers 2
Baylor College of Medicine
Co-authored papers 2
Canada British Columbia Cancer Research Centre, University of British Columbia
Co-authored papers 2
National Center for Biotechnology Information, National Institutes of Health
Co-authored papers 2
Baylor College of Medicine
Co-authored papers 2
Baylor College of Medicine
Co-authored papers 2
Eastern Michigan University.
Co-authored papers 2
University of Houston
Co-authored papers 2
Lund University
Co-authored papers 2
Co-authored papers 2
National Center for Biotechnology Information, National Institutes of Health
Co-authored papers 2